Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels

Releasing Hormone ◽

Androgen Levels

MP50-09 LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST REDUCE SERUM ADRENAL ANDROGEN LEVELS IN PROSTATE CANCER PATIENTS

The Journal of Urology ◽

10.1016/j.juro.2016.02.443 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Yoshiyuki Miyazawa ◽

Haruo Kato ◽

Yosuke Furuya ◽

Takashi Nitta ◽

Yoshitaka Sekine ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Cancer Patients ◽

Adrenal Androgen ◽

Releasing Hormone ◽

Androgen Levels

Luteinizing Hormone (LH)-Releasing Hormone Agonist Reduces Serum Adrenal Androgen Levels in Prostate Cancer Patients: Implications for the Effect of LH on the Adrenal Glands

Journal of Andrology ◽

10.2164/jandrol.112.016493 ◽

2012 ◽

Vol 33 (6) ◽

pp. 1233-1238 ◽

Cited By ~ 14

Author(s):

M. Nishii ◽

M. Nomura ◽

Y. Sekine ◽

H. Koike ◽

H. Matsui ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Cancer Patients ◽

Adrenal Glands ◽

Adrenal Androgen ◽

Releasing Hormone ◽

Lh Releasing Hormone ◽

Androgen Levels

Faculty Opinions recommendation of Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14267095.15779304 ◽

2012 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Biochemical Recurrence ◽

Advanced Prostate Cancer ◽

Second Line ◽

566 ANAMEM: Prospective and observational study to evaluate cognitive changes in prostate cancer patients undergoing luteinizing hormone-releasing hormone analogue treatment

European Urology Supplements ◽

10.1016/s1569-9056(15)60559-0 ◽

2015 ◽

Vol 14 (2) ◽

pp. e566-e566a

Author(s):

J. Morote ◽

A. Tabernero ◽

M.J. Ledo ◽

J.P. Ciria ◽

J.L. Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Observational Study ◽

Cancer Patients ◽

Hormone Analogue ◽

Cognitive Changes ◽

Cancer Treatment and Research - Endocrine Therapies in Breast and Prostate Cancer ◽

Luteinizing Hormone-Releasing Hormone Analogues in the Treatment of Prostate Cancer

10.1007/978-1-4613-1731-9_2 ◽

1988 ◽

pp. 25-38 ◽

Cited By ~ 3

Author(s):

E. David Crawford ◽

Marilyn A. Davis

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer

Drug Management of Prostate Cancer ◽

10.1007/978-1-60327-829-4_2 ◽

2010 ◽

pp. 27-39

Author(s):

Andrew V. Schally ◽

Norman L. Block

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.2011.574611 ◽

2011 ◽

Vol 20 (6) ◽

pp. 769-778 ◽

Cited By ~ 21

Author(s):

Stephen V Liu ◽

Shanshan Liu ◽

Jacek Pinski

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Hormone Receptor ◽

Targeted Agents ◽

Patient compliance in treatment of prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist

Urology ◽

10.1016/0090-4295(93)90265-c ◽

1993 ◽

Vol 42 (5) ◽

pp. 533-535 ◽

Cited By ~ 12

Author(s):

J.Anthony Shaheen ◽

Mohammad Amin ◽

James I. Harty

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Patient Compliance ◽

Lhrh Agonist ◽

MP73-01 ANAMEM: PROSPECTIVE AND OBSERVATIONAL STUDY TO EVALUATE COGNITIVE CHANGES IN PROSTATE CANCER PATIENTS UNDERGOING LUTEINIZING HORMONE-RELEASING HORMONE ANALOGUE TREATMENT

The Journal of Urology ◽

10.1016/j.juro.2015.02.2677 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Juan Morote ◽

Ángel Tabernero ◽

José Luis Álvarez-Ossorio ◽

Juan Pablo Ciria ◽

José Luis Domínguez-Escrig ◽

...

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Observational Study ◽

Cancer Patients ◽

Hormone Analogue ◽

Cognitive Changes ◽

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer

Urology ◽

10.1016/s0090-4295(99)80368-9 ◽

1995 ◽

Vol 46 (6) ◽

pp. 899 ◽

Cited By ~ 2

Author(s):

E. David Crawford

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Advanced Prostate Cancer ◽

Controlled Trial ◽

Hormone Analogue ◽